OBJECTIVE: To assess the effect of intermittent preventive treatment with sulfadoxine and pyrimethamine (IPT-SP) on placental parasitemia and maternal and perinatal outcome. METHODS: We compared placental malaria parasitemia during pregnancy and pregnancy outcome in 2 groups of women receiving antenatal care at University of Benin Teaching Hospital. One group was prophylactically treated with IPT-SP and the other was not treated. RESULTS: The parasitemia rates for peripheral, placental, and cord blood were 11.9%, 11.4%, and 2.7% in the IPT-SP group (n=370) and 19.1%, 22.6%, and 6.2% in the control group (n=371) (P=0.006, P=0.002, and P=0.02, respectively). The treatment reduced the odds of placental parasitemia by 37% (OR 0.63; 95% CI, 0.48-0.81). Peripheral (P=0.002) and placental (P=0.001) parasitemia were significantly reduced in the subgroup of women who took 2 or 3 doses of SP. Fewer women (16.2%) in the IPT-SP group than the control group (23.7%) had symptomatic malaria. Anemia at delivery was significantly lower in the IPT-SP group (10.8 vs 1.6%). The risks of abortion, preterm delivery, and low birth weight were also significantly lower in the IPT-SP group. CONCLUSION: IPT-SP is effective in preventing placental parasitemia, and reduces rates of malaria, maternal anemia, abortion, preterm delivery and low birth weight among pregnant women.
OBJECTIVE: To assess the effect of intermittent preventive treatment with sulfadoxine and pyrimethamine (IPT-SP) on placental parasitemia and maternal and perinatal outcome. METHODS: We compared placental malaria parasitemia during pregnancy and pregnancy outcome in 2 groups of women receiving antenatal care at University of Benin Teaching Hospital. One group was prophylactically treated with IPT-SP and the other was not treated. RESULTS: The parasitemia rates for peripheral, placental, and cord blood were 11.9%, 11.4%, and 2.7% in the IPT-SP group (n=370) and 19.1%, 22.6%, and 6.2% in the control group (n=371) (P=0.006, P=0.002, and P=0.02, respectively). The treatment reduced the odds of placental parasitemia by 37% (OR 0.63; 95% CI, 0.48-0.81). Peripheral (P=0.002) and placental (P=0.001) parasitemia were significantly reduced in the subgroup of women who took 2 or 3 doses of SP. Fewer women (16.2%) in the IPT-SP group than the control group (23.7%) had symptomatic malaria. Anemia at delivery was significantly lower in the IPT-SP group (10.8 vs 1.6%). The risks of abortion, preterm delivery, and low birth weight were also significantly lower in the IPT-SP group. CONCLUSION:IPT-SP is effective in preventing placental parasitemia, and reduces rates of malaria, maternal anemia, abortion, preterm delivery and low birth weight among pregnant women.
Authors: Verner N Orish; Onyekachi S Onyeabor; Johnson N Boampong; Richmond Afoakwah; Ekene Nwaefuna; Samuel Acquah; Adekunle O Sanyaolu; Nnaemeka C Iriemenam Journal: Afr Health Sci Date: 2015-12 Impact factor: 0.927
Authors: Nnaemeka C Iriemenam; Monica Shah; Wangeci Gatei; Anna M van Eijk; John Ayisi; Simon Kariuki; Jodi Vanden Eng; Simon O Owino; Ashima A Lal; Yusuf O Omosun; Kephas Otieno; Meghna Desai; Feiko O ter Kuile; Bernard Nahlen; Julie Moore; Mary J Hamel; Peter Ouma; Laurence Slutsker; Ya Ping Shi Journal: Malar J Date: 2012-07-04 Impact factor: 2.979
Authors: John W Avery; Geoffrey M Smith; Simon O Owino; Demba Sarr; Tamas Nagy; Stephen Mwalimu; James Matthias; Lauren F Kelly; Jayakumar S Poovassery; Joab D Middii; Carlos Abramowsky; Julie M Moore Journal: PLoS One Date: 2012-02-07 Impact factor: 3.240
Authors: Mary C Oguike; Catherine O Falade; Elvis Shu; Izehiuwa G Enato; Ismaila Watila; Ebenezer S Baba; Jane Bruce; Jayne Webster; Prudence Hamade; Sylvia Meek; Daniel Chandramohan; Colin J Sutherland; David Warhurst; Cally Roper Journal: Int J Parasitol Drugs Drug Resist Date: 2016-09-29 Impact factor: 4.077
Authors: Marc C Tahita; Halidou Tinto; Annette Erhart; Adama Kazienga; Robert Fitzhenry; Chantal VanOvermeir; Anna Rosanas-Urgell; Jean-Bosco Ouedraogo; Robert T Guiguemde; Jean-Pierre Van Geertruyden; Umberto D'Alessandro Journal: PLoS One Date: 2015-09-14 Impact factor: 3.240